The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
Molecular Diagnostics and Predictors in Thyroid Cancer
Abstract
BACKGROUND: The accuracy of cancer detection in thyroid nodules by fine-needle aspiration (FNA) cytology and prognostication of thyroid cancer needs further improvement and can benefit from testing for molecular alterations known to occur in thyroid tumors. SUMMARY: Recent studies have demonstrated the feasibility of mutation detection in clinical FNA samples from thyroid nodules and their contribution to improving the diagnostic accuracy of FNA cytology. It appears that molecular testing is most beneficial for thyroid FNA samples with indeterminate cytology, where it can resolve the diagnosis in a significant number of cases. In addition to BRAF mutation, which has been studied most extensively, detection of RAS, RET/PTC, and PAX8/PPARgamma mutations also contribute substantially to cancer diagnosis. Some of these molecular markers, particularly BRAF, can also be used for tumor prognostication. In clinical setting, molecular testing of thyroid FNA samples and surgically removed tumors should utilize a restricted number of techniques that provide high accuracy and specificity of mutation detection. CONCLUSION: Testing for cancer-specific mutations in thyroid FNA samples and surgically removed tumor tissues increases diagnostic accuracy of FNA cytology and offers better prognostication of thyroid cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cooper, D. S., Doherty, G. M., Haugen, B. R., Kloos, R. T., Lee, S. L., Mandel, S. J., Mazzaferri, E. L., McIver, B., Pacini, F., Schlumberger, M., et al. (2009) · Thyroid · doi:10.1089/thy.2009.0110 · Cited by 6,707
Mechanism of Activation of the RAF-ERK Signaling Pathway by Oncogenic Mutations of B-RAF
Wan, P. T. C., Garnett, M. J., Roe, S. M., Lee, S., Niculescu-Duvaz, D., Good, V. M., Project, C. G., Jones, C. M., Marshall, C. J., Springer, C. J., et al. (2004) · Cell · doi:10.1016/s0092-8674(04)00215-6 · Cited by 2,808
Cooper, D. S., Doherty, G. M., Haugen, B. R., Kloos, R. T., Lee, S. L., Mandel, S. J., Mazzaferri, E. L., McIver, B., Sherman, S. I., & Tuttle, R. M. (2006) · Thyroid · doi:10.1089/thy.2006.16.109 · Cited by 2,016
Kimura, E. T., Nikiforova, M. N., Zhu, Z., Knauf, J. A., Nikiforov, Y. E., & Fagin, J. A. (2003) · PubMed · Cited by 1,510
Self-citationManagement of a Solitary Thyroid Nodule
Desforges, J. F., & Mazzaferri, E. L. (1993) · New England Journal of Medicine · doi:10.1056/nejm199302253280807 · Cited by 1,412
BRAF mutation in thyroid cancer
Xing, M. (2005) · Endocrine Related Cancer · doi:10.1677/erc.1.0978 · Cited by 1,300
The role of microRNA genes in papillary thyroid carcinoma
He, H., Jazdzewski, K., Li, W., Liyanarachchi, S., Nagy, R., Volinia, S., Calin, G. A., Liu, C.-G., Franssila, K., Suster, S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509603102 · Cited by 1,215
Nikiforova, M. N., Kimura, E. T., Gandhi, M., Biddinger, P. W., Knauf, J. A., Basolo, F., Zhu, Z., Giannini, R., Salvatore, G., Fusco, A., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030838 · Cited by 1,042
Self-citationBRAF Mutation Predicts a Poorer Clinical Prognosis for Papillary Thyroid Cancer
Xing, M., Westra, W. H., Tufano, R. P., Cohen, Y., Rosenbaum, E., Rhoden, K. J., Carson, K. A., Vasko, V., Larin, A., Tallini, G., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0987 · Cited by 993
Xing, M. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0007 · Cited by 983
Grieco, M., Santoro, M., Berlingieri, M. T., Melillo, R. M., Donghi, R., Bongarzone, I., Pierotti, M. A., Della Ports, G., Fusco, A., & Vecchiot, G. (1990) · Cell · doi:10.1016/0092-8674(90)90659-3 · Cited by 959
BRAF Mutation in Papillary Thyroid Carcinoma
Cohen, Y., Xing, M., Mambo, E., Guo, Z., Wu, G., Trink, B., Beller, U., Westra, W. H., Ladenson, P. W., & Sidransky, D. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.8.625 · Cited by 922
Pathogenetic mechanisms in thyroid follicular-cell neoplasia
Kondo, T., Ezzat, S., & Asa, S. L. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1836 · Cited by 893
Baloch, Z. W., LiVolsi, V. A., Asa, S. L., Rosai, J., Merino, M. J., Randolph, G., Vielh, P., DeMay, R. M., Sidawy, M. K., & Frable, W. J. (2008) · Diagnostic Cytopathology · doi:10.1002/dc.20830 · Cited by 880
PAX8-PPAR γ 1 Fusion in Oncogene Human Thyroid Carcinoma
Kroll, T. G., Sarraf, P., Pecciarini, L., Chen, C.-J., Mueller, E., Spiegelman, B. M., & Fletcher, J. A. (2000) · Science · doi:10.1126/science.289.5483.1357 · Cited by 784
Nikiforova, M. N., Lynch, R. A., Biddinger, P. W., Alexander, E. K., Dorn, G. W., Tallini, G., Kroll, T. G., & Nikiforov, Y. E. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021907 · Cited by 713
Self-citationMolecular Testing for Mutations in Improving the Fine-Needle Aspiration Diagnosis of Thyroid Nodules
Nikiforov, Y. E., Steward, D. L., Robinson-Smith, T. M., Haugen, B. R., Klopper, J. P., Zhu, Z., Fagin, J. A., Falciglia, M., Weber, K., & Nikiforova, M. N. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0247 · Cited by 711
Self-citationBRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC
Soares, P., Trovisco, V., Rocha, A. S., Lima, J., Castro, P., Preto, A., Máximo, V., Botelho, T., Seruca, R., & Sobrinho-Simões, M. (2003) · Oncogene · doi:10.1038/sj.onc.1206706 · Cited by 679
Nikiforov, Y. E., Rowland, J. M., Bove, K. E., Monforte-Muñoz, H., & Fagin, J. A. (1997) · PubMed · Cited by 666
Self-citationMicroRNA Expression Profiling of Thyroid Tumors: Biological Significance and Diagnostic Utility
Nikiforova, M. N., Tseng, G. C., Steward, D., Diorio, D., & Nikiforov, Y. E. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2696 · Cited by 582
Self-citationDiagnosis of “follicular neoplasm”: A gray zone in thyroid fine‐needle aspiration cytology
Baloch, Z. W., Fleisher, S., LiVolsi, V. A., & Gupta, P. K. (2002) · Diagnostic Cytopathology · doi:10.1002/dc.10043 · Cited by 546
Clinical Implication of Hot Spot BRAF Mutation, V599E, in Papillary Thyroid Cancers
Namba, H., Nakashima, M., Hayashi, T., Hayashida, N., Maeda, S., Rogounovitch, T. I., Ohtsuru, A., Saenko, V. A., Kanematsu, T., & Yamashita, S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030305 · Cited by 533
Ricarte-Filho, J. C., Ryder, M., Chitale, D. A., Rivera, M., Heguy, A., Ladanyi, M., Janakiraman, M., Solit, D., Knauf, J. A., Tuttle, R. M., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0727 · Cited by 529
Elisei, R., Ugolini, C., Viola, D., Lupi, C., Biagini, A., Giannini, R., Romei, C., Miccoli, P., Pinchera, A., & Basolo, F. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0607 · Cited by 528
MicroRNA deregulation in human thyroid papillary carcinomas
Pallante, P., Visone, R., Ferracin, M., Ferraro, A., Berlingieri, M. T., Troncone, G., Chiappetta, G., Liu, C. G., Santoro, M., Negrini, M., et al. (2006) · Endocrine-Related Cancer · doi:10.1677/erc.1.01209 · Cited by 527
Adeniran, A. J., Zhu, Z., Gandhi, M., Steward, D. L., Fidler, J. P., Giordano, T. J., Biddinger, P. W., & Nikiforov, Y. E. (2006) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000176432.73455.1b · Cited by 495
Self-citationRET/PTC Rearrangement in Thyroid Tumors
Nikiforov, Y. E. (2002) · Endocrine Pathology · doi:10.1385/ep:13:1:03 · Cited by 489
Self-citationThe Prevalence and Prognostic Value of BRAF Mutation in Thyroid Cancer
Kebebew, E., Weng, J., Bauer, J., Ranvier, G., Clark, O. H., Duh, Q.-Y., Shibru, D., Bastian, B., & Griffin, A. (2007) · Annals of Surgery · doi:10.1097/sla.0b013e318148563d · Cited by 480
Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer
Ciampi, R., Knauf, J. A., Kerler, R., Gandhi, M., Zhu, Z., Nikiforova, M. N., Rabes, H. M., Fagin, J. A., & Nikiforov, Y. E. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523237 · Cited by 461
Self-citationHou, P., Liu, D., Shan, Y., Hu, S., Studeman, K., Condouris, S., Wang, Y., Trink, A., El-Naggar, A. K., Tallini, G., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1125 · Cited by 418
High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis.
Lemoine, N. R., Mayall, E. S., Wyllie, F. S., Williams, E. D., Goyns, M. H., Stringer, B. M. J., & Wynford‐Thomas, D. (1989) · PubMed · Cited by 417
Visone, R., Russo, L., Pallante, P., De Martino, I., Ferraro, A., Leone, V., Borbone, E., Petrocca, F., Alder, H., Croce, C. M., et al. (2007) · Endocrine-Related Cancer · doi:10.1677/erc-07-0129 · Cited by 417
Follicular variant of papillary thyroid carcinoma: A clinicopathologic study of a problematic entity
Liu, J., Singh, B., Tallini, G., Carlson, D. L., Katabi, N., Shaha, A., Tuttle, R. M., & Ghossein, R. A. (2006) · Cancer · doi:10.1002/cncr.22138 · Cited by 416
Knauf, J. A., Ma, X., Smith, E. P., Zhang, L., Mitsutake, N., Liao, X.-H., Refetoff, S., Nikiforov, Y. E., & Fagin, J. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0047 · Cited by 414
Self-citationBRAF Mutations in Papillary Thyroid Carcinomas Inhibit Genes Involved in Iodine Metabolism
Durante, C., Puxeddu, E., Ferretti, E., Morisi, R., Moretti, S., Bruno, R., Barbi, F., Avenia, N., Scipioni, A., Verrienti, A., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2707 · Cited by 397
Lupi, C., Giannini, R., Ugolini, C., Proietti, A., Berti, P., Minuto, M., Materazzi, G., Elisei, R., Santoro, M., Miccoli, P., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1179 · Cited by 391
Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype.
Santoro, M., Carlomagno, F., Hay, I. D., Herrmann, M. A., Grieco, M., Melillo, R., Pierotti, M. A., Bongarzone, I., Della Porta, G., & Berger, N. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115743 · Cited by 390
Riesco-Eizaguirre, G., Gutiérrez-Martínez, P., García-Cabezas, M. A., Nistal, M., & Santisteban, P. (2006) · Endocrine-Related Cancer · doi:10.1677/erc.1.01119 · Cited by 376
Zhu, Z., Gandhi, M., Nikiforova, M. N., Fischer, A. H., & Nikiforov, Y. E. (2003) · American Journal of Clinical Pathology · doi:10.1309/nd8d-9laj-trct-g6qd · Cited by 371
Self-citationras Mutations Are Associated With Aggressive Tumor Phenotypes and Poor Prognosis in Thyroid Cancer
Garcia-Rostan, G., Zhao, H., Camp, R. L., Pollan, M., Herrero, A., Pardo, J., Wu, R., Carcangiu, M. L., Costa, J., & Tallini, G. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.10.130 · Cited by 368
Rabes, H. M., Demidchik, E. P., Sidorow, J. D., Lengfelder, E., Beimfohr, C., Hoelzel, D., & Klugbauer, S. (2000) · PubMed · Cited by 367
Santoro, M. M., Dathan, N. A., Berlingieri, M. T., Bongarzone, I., Paulin, C., Grieco, M., Pierotti, M. A., Vecchio, G., & Fusco, A. (1994) · PubMed · Cited by 366
Point Mutations of Ras Oncogenes are an Early Event in Thyroid Tumorigenesis
Namba, H., Rubin, S. A., & Fagin, J. A. (1990) · Molecular Endocrinology · doi:10.1210/mend-4-10-1474 · Cited by 356
RET as a Diagnostic and Therapeutic Target in Sporadic and Hereditary Endocrine Tumors
de Groot, J. W. B., Links, T. P., Plukker, J. T. M., Lips, C. J. M., & Hofstra, R. M. W. (2006) · Endocrine Reviews · doi:10.1210/er.2006-0017 · Cited by 356
Zhu, Z., Gandhi, M., Nikiforova, M. N., Fischer, A. H., & Nikiforov, Y. E. (2003) · American Journal of Clinical Pathology · doi:10.1309/nd8d9lajtrctg6qd · Cited by 355
Self-citationPAX8-PPARγ Rearrangement in Thyroid Tumors: RT-PCR and Immunohistochemical Analyses
Nikiforova, M. N., Biddinger, P. W., Caudill, C. M., Kroll, T. G., & Nikiforov, Y. E. (2002) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200208000-00006 · Cited by 349
Self-citationMutation of the PIK3CA Gene in Anaplastic Thyroid Cancer
García-Rostán, G., Costa, A. M., Pereira-Castro, I., Salvatore, G., Hernandez, R., Hermsem, M. J. A., Herrero, A., Fusco, A., Cameselle-Teijeiro, J., & Santoro, M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4259 · Cited by 338
Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas
Jhiang, S. M. (1996) · Endocrinology · doi:10.1210/en.137.1.375 · Cited by 314
Tallini, G., Santoro, M. M., Helie, M., Carlomagno, F., Salvatore, G., Chiappetta, G., Carcangiu, M. L., & Fusco, A. (1998) · PubMed · Cited by 302
A Limited Set of Human MicroRNA Is Deregulated in Follicular Thyroid Carcinoma
Weber, F., Teresi, R. E., Broelsch, C. E., Frilling, A., & Eng, C. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0693 · Cited by 293
Sclabas, G. M., Staerkel, G. A., Shapiro, S. E., Fornage, B. D., Sherman, S. I., Vassillopoulou-Sellin, R., Lee, J. E., & Evans, D. B. (2003) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2003.08.015 · Cited by 274
Frattini, M., Ferrario, C., Bressan, P., Balestra, D., De Cecco, L., Mondellini, P., Bongarzone, I., Collini, P., Gariboldi, M., Pilotti, S., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207980 · Cited by 266
Presence of mutations in all three ras genes in human thyroid tumors.
Suarez, H. G., Ja, D. V., Severino, M. E., Caillou, B., Schlumberger, M. J., Tubiana, M., Parmentier, C., & Monier, R. (1990) · PubMed · Cited by 262
Salvatore, G., Giannini, R., Faviana, P., Caleo, A., Migliaccio, I., Fagin, J. A., Nikiforov, Y. E., Troncone, G., Palombini, L., Basolo, F., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032221 · Cited by 259
Self-citationManagement of Low-Risk Differentiated Thyroid Cancer
Mazzaferri, E. L. (2007) · Endocrine Practice · doi:10.4158/ep.13.5.498 · Cited by 256
The RET/PTC3 oncogene: metastatic solid-type papillary carcinomas in murine thyroids.
Powell, D. J., Russell, J. P., Nibu, K., Li, G., Rhee, E. N., Liao, M., Goldstein, M., Keane, W. M., Santoro, M. M., Fusco, A., et al. (1998) · PubMed · Cited by 255
Xing, M., Tufano, R. P., Tufaro, A. P., Basaria, S., Ewertz, M., Rosenbaum, E., Byrne, P. J., Wang, J., Sidransky, D., & Ladenson, P. W. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032050 · Cited by 251
Castro, P., Rebocho, A. P., Soares, R. J., Magalhães, J., Roque, L., Trovisco, V., Vieira de Castro, I., Cardoso-de-Oliveira, M., Fonseca, E., Soares, P., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1336 · Cited by 240
Kim, T. Y., Kim, W. B., Rhee, Y. S., Song, J. Y., Kim, J. M., Gong, G., Lee, S., Kim, S. Y., Kim, S. C., Hong, S. J., et al. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02605.x · Cited by 238
Santoro, M., Chiappetta, G., Cerrato, A., Salvatore, D., Zhang, L., Manzo, G., Picone, A., Portella, G., Santelli, G., Vecchio, G., et al. (1996) · PubMed · Cited by 234
Activated ras oncogenes in human thyroid cancers.
Lemoine, N. R., Mayall, E. S., Wyllie, F. S., Farr, C. J., Hughes, D., Padua, R. A., Thurston, V., Williams, E. D., & Wynford‐Thomas, D. (1988) · PubMed · Cited by 233
Fenton, C. L., Lukes, Y., Nicholson, D., Dinauer, C. A., Francis, G. L., & Tuttle, R. M. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.3.6472 · Cited by 225
RET Oncogene Activation in Papillary Thyroid Carcinoma
Tallini, G., Asa, S. L., & Fuller, G. N. (2001) · Advances in Anatomic Pathology · doi:10.1097/00125480-200111000-00005 · Cited by 223
Parwani, A. V. (2007) · Yearbook of Pathology and Laboratory Medicine · doi:10.1016/s1077-9108(08)70389-x · Cited by 221
Prevalence of Ras mutations in thyroid neoplasia
Esapa, C. T., Johnson, S. J., Kendall‐Taylor, P., Lennard, T. W. J., & Harris, P. E. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00704.x · Cited by 220
Tetzlaff, M. T., Liu, A., Xu, X., Master, S. R., Baldwin, D. A., Tobias, J. W., Livolsi, V. A., & Baloch, Z. W. (2007) · Endocrine Pathology · doi:10.1007/s12022-007-0023-7 · Cited by 217
Bongarzone, I., Butti, M. G., Coronelli, S., Borrello, M. G., Santoro, M., Mondellini, P., Pilotti, S., Fusco, A., Porta, G., & Pierotti, M. A. (1994) · PubMed · Cited by 215
MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma
Chen, Y.-T., Kitabayashi, N., Zhou, X. K., Fahey, T. J., & Scognamiglio, T. (2008) · Modern Pathology · doi:10.1038/modpathol.2008.105 · Cited by 210
Zhu, Z., Ciampi, R., Nikiforova, M. N., Gandhi, M., & Nikiforov, Y. E. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1006 · Cited by 209
Self-citationDwight, T., Thoppe, S. R., Foukakis, T., Lui, W. O., Wallin, G., Höög, A., Frisk, T., Larsson, C., & Zedenius, J. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021690 · Cited by 208
Cohen, Y., Rosenbaum, E., Clark, D. P., Zeiger, M. A., Umbricht, C. B., Tufano, R. P., Sidransky, D., & Westra, W. H. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0273 · Cited by 207
Fenton, C. L. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.3.1170 · Cited by 190
Cheung, C. C. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.5.2187 · Cited by 180
Bongarzone, I., Vigneri, P. G., Mariani, L., Collini, P., Pilotti, S., & Pierotti, M. A. (1998) · PubMed · Cited by 178
Genetic and Biological Subgroups of Low-Stage Follicular Thyroid Cancer
French, C. A., Alexander, E. K., Cibas, E. S., Nose, V., Laguette, J., Faquin, W., Garber, J., Moore, F., Fletcher, J. A., Larsen, P. R., et al. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63902-8 · Cited by 175
Begum, S., Rosenbaum, E., Henrique, R., Cohen, Y., Sidransky, D., & Westra, W. H. (2004) · Modern Pathology · doi:10.1038/modpathol.3800198 · Cited by 175
Ras Oncogene Mutations in Benign and Malignant Thyroid Neoplasms
KARGA, H., LEE, J.-K., VICKERY, A. L., THOR, A., GAZ, R. D., & JAMESON, J. L. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-4-832 · Cited by 175
Diagnostic pathology and molecular genetics of the thyroid
Nikiforov, Y. E., Biddinger, P. W., & Thompson, L. D. �. (2009) · Cited by 174
Self-citationChung, K., Yang, S. K., Lee, G. K., Kim, E. Y., Kwon, S., Lee, S. H., Park, D. J., Lee, H. S., Cho, B. Y., Lee, E. S., et al. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02646.x · Cited by 171
Basolo, F., Pisaturo, F., Pollina, L. E., Fontanini, G., Elisei, R., Molinaro, E., Iacconi, P., Miccoli, P., & Pacini, F. (2000) · Thyroid · doi:10.1089/thy.2000.10.19 · Cited by 155
Sapio, M. R., Posca, D., Raggioli, A., Guerra, A., Marotta, V., Deandrea, M., Motta, M., Limone, P. P., Troncone, G., Caleo, A., et al. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02800.x · Cited by 149
Pyrosequencing Analysis for Detection of a BRAFV600E Mutation in an FNAB Specimen of Thyroid Nodules
Kim, S. K., Kim, D., Han, H. S., Kim, W. S., Kim, S. J., Moon, W., Oh, S. Y., & Hwang, T. S. (2008) · Diagnostic Molecular Pathology · doi:10.1097/pdm.0b013e31815d059d · Cited by 146
Unger, K., Zitzelsberger, H. F., Salvatore, G., Santoro, M. M., Ti, B., Braselmann, H., Kastner, P., Zurnadzhy, L., Tronko, N., Hutzler, P., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031870 · Cited by 132
Selective activation of ras oncogenes in follicular and undifferentiated thyroid carcinomas
Manenti, G., Pilotti, S., Re, F. C., Porta, G., & Pierotti, M. A. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(94)90130-9 · Cited by 126
MicroRNA Expression Profiles in Thyroid Tumors
Nikiforova, M. N., Chiosea, S. I., & Nikiforov, Y. E. (2009) · Endocrine Pathology · doi:10.1007/s12022-009-9069-z · Cited by 125
Self-citationN-ras mutation: an independent prognostic factor for aggressiveness of papillary thyroid carcinoma.
Hara, H., Fulton, N. C., YASHIRO, T., Ito, K., DeGroot, L. J., & Kaplan, E. L. (1994) · PubMed · Cited by 124
Zatelli, M. C., Trasforini, G., Leoni, S., Frigato, G., Buratto, M., Tagliati, F., Rossi, R., Cavazzini, L., Roti, E., & Uberti, E. C. D. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0353 · Cited by 111
Expression of PAX8-PPAR 1 Rearrangements in Both Follicular Thyroid Carcinomas and Adenomas
Marques, A. R. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.8.3947 · Cited by 110
Role of ras mutation in the progression of thyroid carcinoma of follicular epithelial origin
Motoi, N., Sakamoto, A., Yamochi, T., Horiuchi, H., Motoi, T., & Machinami, R. (2000) · Pathology - Research and Practice · doi:10.1016/s0344-0338(00)80015-1 · Cited by 106
Sapio, M. R., Posca, D., Troncone, G., Pettinato, G., Palombini, L., Rossi, G., Fenzi, G., & Vitale, M. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02072 · Cited by 102
Changing Trends in Thyroid Practice: Understanding Nodular Thyroid Disease
Gharib, H. (2004) · Endocrine Practice · doi:10.4158/ep.10.1.31 · Cited by 101
Prevalence of Activating ras Mutations in Morphologically Characterized Thyroid Nodules
Ezzat, S., Zheng, L., KOLENDA, J., SAFARIAN, A., Freeman, J. L., & Asa, S. L. (1996) · Thyroid · doi:10.1089/thy.1996.6.409 · Cited by 98
Pizzolanti, G., Russo, L., Richiusa, P., Bronte, V., Nuara, R. B., Rodolico, V., Amato, M. C., Smeraldi, L., Sisto, P. S., Nucera, M., et al. (2007) · Thyroid · doi:10.1089/thy.2007.0008 · Cited by 95
Sapio, M. R., Guerra, A., Posca, D., Limone, P. P., Deandrea, M., Motta, M., Troncone, G., Caleo, A., Vallefuoco, P., Rossi, G., et al. (2007) · Endocrine Related Cancer · doi:10.1677/erc-07-0147 · Cited by 91
Rodolico, V., Cabibi, D., Pizzolanti, G., Richiusa, P., Gebbia, N., Martorana, A., Russo, A. D., Amato, M. C., Galluzzo, A., & Giordano, C. S. D. S. (2007) · Cancer · doi:10.1002/cncr.22912 · Cited by 79
HOOK3-RET : a novel type of RET/PTC rearrangement in papillary thyroid carcinoma
Ciampi, R., Giordano, T. J., Wikenheiser‐Brokamp, K. A., Koenig, R. J., & Nikiforov, Y. E. (2007) · Endocrine Related Cancer · doi:10.1677/erc-07-0039 · Cited by 79
Self-citationA Novel Complex BRAF Mutation Detected in a Solid Variant of Papillary Thyroid Carcinoma
Chiosea, S. I., Nikiforova, M. N., Zuo, H., Ogilvie, J. B., Gandhi, M., Seethala, R. R., Ohori, N. P., & Nikiforov, Y. E. (2009) · Endocrine Pathology · doi:10.1007/s12022-009-9073-3 · Cited by 76
Self-citationJo, Y. S., Huang, S., Kim, Y., Lee, I. J., Kim, S. S., Kim, J., Oh, T., Moon, Y., An, S., Ro, H.-K., et al. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03293.x · Cited by 69
Domingues, R., Mendonça, E., Sobrinho, L. G., et al. (2005) · Cytopathology · doi:10.1111/j.1365-2303.2004.00223.x · Cited by 60
Cited by
Cooper, D. S., Doherty, G. M., Haugen, B. R., Kloos, R. T., Lee, S. L., Mandel, S. J., Mazzaferri, E. L., McIver, B., Pacini, F., Schlumberger, M., et al. (2009) · Thyroid · doi:10.1089/thy.2009.0110 · Cited by 6,707
Molecular genetics and diagnosis of thyroid cancer
Nikiforov, Y. E., & Nikiforova, M. N. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.142 · Cited by 1,011
Self-citationNikiforov, Y. E., Ohori, N. P., Hodak, S. P., Carty, S. E., LeBeau, S. O., Ferris, R. L., Yip, L., Seethala, R. R., Tublin, M. E., Stang, M. T., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1469 · Cited by 790
Self-citationProgress in molecular-based management of differentiated thyroid cancer
Xing, M., Haugen, B. R., & Schlumberger, M. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60109-9 · Cited by 573
Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies
Molinaro, E., Romei, C., Biagini, A., Sabini, E., Agate, L., Mazzeo, S., Materazzi, G., Sellari-Franceschini, S., Ribechini, A., Torregrossa, L., et al. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.76 · Cited by 483
Metadata
- Authors
- Nikiforova, M. N., & Nikiforov, Y. E.
- Venue
- Thyroid
- Publisher
- SAGE Publications
- Published
- 2009-12
- Volume
- 19
- Issue
- 12
- Pages
- 1351-1361
- ISSN
- 1050-7256 (ISSN-L)
- 1557-9077
- OpenAlex
- W1994051894
- Cited by
- 309
- References
- 99
- FWCI
- 22.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.